Immunologic Agents : Passive Immunity (Antiserums) : Antiserums from Human Source
IHYPE1 “Hyper Hepatitis B Immune Globulin (human) injection” 0.165 g/ml; 1 ml/vial
適應症：血清類（預防B型肝炎之感染）。
Usual dose:
Hepatitis postexposure, prophylaxis: IM, 0.06 mL/kg as a single dose within 14 days of exposure, plus hepatitis B vaccine series.
Adverse effect:
Common: erythema at injection site, injection site pain, nausea, vomiting, ecchymosis, leukopenia, ast/sgot level raised, joint stiffness, myalgia, headache, serum creatinine raised, alkaline phosphatase raised, malaise.
健保使用規範：應以HBsAg (-)，Anti-HBc (-)之醫院工作人員為主，且傳染者需為HBsAg (+)。
Related Entries
(Visited 51 times, 1 visits today)